Sterling Pharmaceuticals Ltd is committed to continuous innovation in pharmaceutical formulation and product development. Our Research and Development activities support our contract manufacturing services by ensuring that new and existing products meet the evolving needs of patients, healthcare providers, and global regulatory frameworks.

Working in tandem with our manufacturing and quality teams, our R&D function focuses on:

• Enhancing formulations for oral and topical liquid products.
• Supporting the development of solid dosage forms in small batches.
• Improving product stability, palatability, and patient compliance.
• Generating technical documentation for UK and international registrations.

Our formulation work is underpinned by robust in-house testing capabilities, allowing for detailed characterisation of chemical composition, stability, and performance across a wide range of dosage forms. This enables us to refine product designs, respond to client specifications, and ensure regulatory readiness from an early development stage.

Sterling takes a pragmatic approach to R&D by prioritising customer-led innovation, regulatory compliance, and scalability. Our teams are actively involved in adjusting formulations for diverse export markets, particularly where healthcare systems require tailored or unlicensed medicines.

Our goal is to remain responsive, reliable, and innovative — delivering effective pharmaceutical solutions rooted in scientific integrity and technical excellence.